scispace - formally typeset
L

Lydia Doan

Researcher at University of Nevada, Reno

Publications -  5
Citations -  64

Lydia Doan is an academic researcher from University of Nevada, Reno. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 2, co-authored 2 publications receiving 21 citations.

Papers
More filters
Journal ArticleDOI

Host plant associated enhancement of immunity and survival in virus infected caterpillars

TL;DR: Results suggest that plant secondary metabolites are important for survival against a viral pathogen and may be associated with activation of PO.
Journal ArticleDOI

An arthropod survival strategy in a frequently burned forest

TL;DR: It is suggested that tiny, yet highly sensitive, sensory adaptations may aid in an interesting arthropod behavior that takes place before the fire arrives: insect ears.
Journal ArticleDOI

Honeysuckle (Lonicera japonica) and Huangqi (Astragalus membranaceus) Suppress SARS-CoV-2 Entry and COVID-19 Related Cytokine Storm in Vitro

TL;DR: It is demonstrated that honeysuckle and Huangqi have the potential to be used as an inhibitor of SARS-CoV-2 virus entry that warrants further in vivo analysis and functional assessment of miRNAs to confirm their clinical importance.
Journal ArticleDOI

Virofree, an Herbal Medicine-Based Formula, Interrupts the Viral Infection of Delta and Omicron Variants of SARS-CoV-2

TL;DR: The inhibitory effect of Virofree was repurposed as a potential herbal medicine to combat COVID-19 and highlighted the entry of Delta and Omicron variants of SARS-CoV-2, which have not had any effective treatments during the emergence of the new variants spreading.
Journal ArticleDOI

Repurposing Astragalus Polysaccharide PG2 for Inhibiting ACE2 and SARS-CoV-2 Spike Syncytial Formation and Anti-Inflammatory Effects

TL;DR: Astragalus polysaccharide (PG2) as discussed by the authors is a repurposed drug that possesses the potential to prevent WT SARS-CoV-2 S-mediated syncytia formation with the host cells; it also inhibits the binding of S proteins of WT, alpha, and beta strains to the recombinant ACE2 and halts severe COVID-19 development by regulating the polarization of macrophages to M2 cells.